EP0411684A3

New antigenically active proteins/peptides, and feline infectious virus (fipv)-vaccines

Abstract

The invention relates to two new antigenic proteins/pepti­des which can be used to stimulate the immunity of cats (Felidae) against feline infectious peritonitis virus (FIPV), i.e. the M-protein and the N-protein. The invention also relates to vaccines which comprise such antigenic proteins or peptides. The nucleotide sequence and amino acid sequence of the M-­protein and the N-protein are indicated in figure 1.

Term

Term ended

Projected expiry passed 10 July 2010, 16.2 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

Every citation, both waysCites: the store holds 2 of 3

Citations
DocumentRelationOfficeCategoryCited during
EP0264979A1CitesEuropean Patent Office (EPO)YSearch report
EP0376744A1CitesEuropean Patent Office (EPO)XPSearch report
VIROLOGY, vol. 167, 1988, pages 370-376, Academic Press, Inc.; R.J. DE GROOT et al.: "Sequence analysis of the 3' end of the feline coronavirus FIPV 79-1146 genome: Comparison with the genome of porcine cornonavirus TGEV reveals large insertions"Non-patentSearch report
J. GEN. VIROL., vol. 68, 1987, pages 995-1002, SGM, GB; R.J. DE GROOT et al.: "Intracellular RNAs of the feline infectious peritonitis coronavirus strain 79-1146"Non-patentSearch report